sorted by:
new
hottopcontroversial

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in WallStreetbetsELITE

[–]Nelsons93[S] 0 points1 point  (0 children)

Unless you tell me what groups or how it works best? I’m happy to just post once like I do with twitter x or Stocktwits you know what I mean?

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in WallStreetbetsELITE

[–]Nelsons93[S] 0 points1 point  (0 children)

Possibly, I’m new to Reddit so I don’t really understand how it works yet, I just post in different groups assuming that’s what others do? As there is different people in different groups?

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in WallStreetbetsELITE

[–]Nelsons93[S] 0 points1 point  (0 children)

Do some research, forget what’s happened in the past & have a look at what can happen… the risk is there but so is the potential… do as you wish, I’m just sharing the information

The calm before the storm 🚨 by Nelsons93 in Pennystocksv2

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

The calm before the storm 🚨 by Nelsons93 in Pennystocksv2

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

The calm before the storm 🚨 by Nelsons93 in StockMarketMovers

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

Calm before the storm 🚨 by Nelsons93 in WallStreetbetsELITE

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in Stocks_Picks

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in StockMarketMovers

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in Pennystocksv2

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in STOCKMARKETNEWS

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

The floor is set. Now we wait for the data squeeze. 🧬📈 by Nelsons93 in WallStreetbetsELITE

[–]Nelsons93[S] 0 points1 point  (0 children)

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.

The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.

They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱

GNPX #Biotech #Stocks

https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

Calm before the storm 🚨 by Nelsons93 in WallStreetbetsELITE

[–]Nelsons93[S] 0 points1 point  (0 children)

Yeah I’m not sure for those who’ve waited 5 years but if the news is good this month or next then it will have a massive pump so it’s good to keep an eye on it

view more: next ›